John Trainer
Chief Operating Officer bij IMMUNOCORE HOLDINGS PLC
Profiel
Presently, John Trainer is Chief Operating Officer & Senior Vice President at Immunocore Holdings Plc.
He is also on the board of Corvidia Therapeutics, Inc., Fujifilm Kyowa Kirin Biologics Co., Ltd.
and Archigen Biotech Ltd.
In the past he occupied the position of Chief Financial Officer at NexImmune, Inc. and Vice President & Head-Partnering & Strategy at AstraZeneca, Inc.
He received an MBA from Harvard Business School and an undergraduate degree from Harvard College.
Actieve functies van John Trainer
Bedrijven | Functie | Begin |
---|---|---|
IMMUNOCORE HOLDINGS PLC | Chief Operating Officer | 01-10-2023 |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Director/Board Member | - |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Director/Board Member | - |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | Director/Board Member | - |
Eerdere bekende functies van John Trainer
Bedrijven | Functie | Einde |
---|---|---|
NEXIMMUNE, INC. | Director of Finance/CFO | 02-09-2023 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
Opleiding van John Trainer
Harvard Business School | Masters Business Admin |
Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NEXIMMUNE, INC. | Health Technology |
IMMUNOCORE HOLDINGS PLC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | Health Technology |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Health Technology |